^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    35-gene signature

    2years
    Ferritinophagy Is a Druggable Vulnerability of Quiescent Leukemic Stem Cells (ASH 2023)
    These findings highlight the critical vulnerability of quiescent LSCs to ferritinophagy. Thus, NCOA4 inhibition represents an innovative therapeutic approach for AML patients.
    IO biomarker
    |
    CD34 (CD34 molecule) • NCOA4 (Nuclear Receptor Coactivator 4)
    |
    35-gene signature